A popular brand of cream designed to soothe a baby's nappy rash has been recalled after it was found to create a rash instead. AddedFeb 21st, 2023 Billowing smoke has forced shoppers from ...

The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission ...

Furry friends may provide more than forever friendship to children. Here's what a new study suggests about pet parenthood and ...

Exposure to extreme heat is risky for children, the elderly, people working outdoors and those with certain health conditions ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

POD is an inflammatory facial ... ups of the rash. POD often follows a chronic, fluctuating course and may be exacerbated by overuse of moisturizers, cosmetics, and topical creams.

“If Vaseline petroleum jelly and Pond’s cold cream had a baby, it would be Albolene,” says Waldorf. For your second cleanse, you want to keep hydrating your skin. Dr. Michelle ...

The hottest days of the year so far will bring an increased risk of heatstroke in children – here's how to spot the signs and keep them safe.

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for ruxolitinib cream (Opzelura ® ...